Fulgent Genetics (FLGT) Gross Margin (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Gross Margin data on file, last reported at 30.21% in Q1 2026.

• Quarterly Gross Margin fell 838.0% year-over-year to 30.21% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 52.24% (up 1344.0% YoY) and the FY2025 annual result came in at 40.56%, up 274.0% from the prior year.
• Gross Margin retreated to 30.21% in Q1 2026 per FLGT's latest filing, from 8145.5% in the prior quarter.
• The five-year high for Gross Margin was 8145.5% in Q4 2025, with the low at 28.43% in Q1 2023.
• Average Gross Margin over 5 years is 547.65%, with a median of 40.19% recorded in 2024.
• Year-over-year, Gross Margin tumbled 4730 bps in 2023 and jumped 810371 bps in 2025.
• Fulgent Genetics' Gross Margin stood at 43.63% in 2022, then retreated by 18 bps to 35.78% in 2023, then climbed by 17 bps to 41.79% in 2024, then soared by 19392 bps to 8145.5% in 2025, then tumbled by 100 bps to 30.21% in 2026.
• Business Quant data shows FLGT's Gross Margin at 30.21% in Q1 2026, 8145.5% in Q4 2025, and 42.24% in Q3 2025.